(Q40181016)

18 September 2017

The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2. (English)

1 reference

18 September 2017

L Beke

1

1 reference

18 September 2017

M Nuytten

2

1 reference

18 September 2017

A Van Eynde

3

1 reference

18 September 2017

M Beullens

4

1 reference

18 September 2017

M Bollen

5

1 reference

18 September 2017

language of work or name

English

0 references

publication date

22 January 2007

1 reference

18 September 2017

1 reference

18 September 2017

26

1 reference

18 September 2017

4590-4595

1 reference

18 September 2017

31

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210248

18 September 2017

0 references

cites work

A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210248

7 January 2021

Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210248

7 January 2021

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210248

7 January 2021

SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210248

7 January 2021

Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210248

7 January 2021

Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210248

7 January 2021

A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: implication in tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210248

7 January 2021

The diverse functions of histone lysine methylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210248

7 January 2021

Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210248

7 January 2021

The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210248

7 January 2021

A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210248

7 January 2021

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210248

7 January 2021

Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210248

7 January 2021

The polycomb group protein EZH2 is involved in progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210248

7 January 2021

The Polycomb group protein EZH2 directly controls DNA methylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210248

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210248

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference